Literature DB >> 26646763

Review: circulating tumor cells in the practice of breast cancer oncology.

R Ramos-Medina1, F Moreno2, S Lopez-Tarruella3, M Del Monte-Millán3, I Márquez-Rodas3, E Durán4, Y Jerez3, J A Garcia-Saenz2, I Ocaña4, S Andrés4, T Massarrah5, M González-Rivera4, M Martin4,3.   

Abstract

The primary cause of tumor-related death in breast cancer is still represented by distant metastasization. The dissemination of tumor cells from the primary tumor to distant sites through bloodstream cannot be early detected by standard imaging methods. Circulating tumor cells (CTCs) play a major role in the metastatic spread of breast cancer. Different analytical systems for CTCs isolation and detection have been developed and novel areas of research are directed towards developing assays for CTCs molecular characterization. This review describes the current state of art on CTCs detection techniques and the present and future clinical implications of CTCs enumeration and characterization.

Entities:  

Keywords:  Circulating tumor cells; Clinical applications; Detection; Enumeration; Markers

Mesh:

Substances:

Year:  2015        PMID: 26646763     DOI: 10.1007/s12094-015-1460-2

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  60 in total

Review 1.  Essentials of circulating tumor cells for clinical research and practice.

Authors:  Marian Liberko; Katarina Kolostova; Vladimir Bobek
Journal:  Crit Rev Oncol Hematol       Date:  2013-07-05       Impact factor: 6.312

Review 2.  Circulating tumor cells as emerging tumor biomarkers in breast cancer.

Authors:  Evi S Lianidou; Athina Markou
Journal:  Clin Chem Lab Med       Date:  2011-07-29       Impact factor: 3.694

3.  Pathological response and circulating tumor cell count identifies treated HER2+ inflammatory breast cancer patients with excellent prognosis: BEVERLY-2 survival data.

Authors:  Jean-Yves Pierga; Thierry Petit; Christelle Lévy; Jean-Marc Ferrero; Mario Campone; Joseph Gligorov; Florence Lerebours; Henri Roché; Thomas Bachelot; Emmanuelle Charafe-Jauffret; Jacques Bonneterre; Juana Hernandez; François-Clément Bidard; Patrice Viens
Journal:  Clin Cancer Res       Date:  2014-12-23       Impact factor: 12.531

4.  Circulating tumour cells in non-metastatic breast cancer: a prospective study.

Authors:  Anthony Lucci; Carolyn S Hall; Ashutosh K Lodhi; Anirban Bhattacharyya; Amber E Anderson; Lianchun Xiao; Isabelle Bedrosian; Henry M Kuerer; Savitri Krishnamurthy
Journal:  Lancet Oncol       Date:  2012-06-06       Impact factor: 41.316

5.  Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy.

Authors:  W Fraser Symmans; Florentia Peintinger; Christos Hatzis; Radhika Rajan; Henry Kuerer; Vicente Valero; Lina Assad; Anna Poniecka; Bryan Hennessy; Marjorie Green; Aman U Buzdar; S Eva Singletary; Gabriel N Hortobagyi; Lajos Pusztai
Journal:  J Clin Oncol       Date:  2007-09-04       Impact factor: 44.544

Review 6.  Clinical application of circulating tumor cells in breast cancer.

Authors:  Leonie H A Broersen; Gabi W van Pelt; Rob A E M Tollenaar; Wilma E Mesker
Journal:  Cell Oncol (Dordr)       Date:  2013-11-19       Impact factor: 6.730

7.  Isolation of rare cells from cell mixtures by dielectrophoresis.

Authors:  Peter R C Gascoyne; Jamileh Noshari; Thomas J Anderson; Frederick F Becker
Journal:  Electrophoresis       Date:  2009-04       Impact factor: 3.535

8.  Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data.

Authors:  François-Clément Bidard; Dieter J Peeters; Tanja Fehm; Franco Nolé; Rafael Gisbert-Criado; Dimitrios Mavroudis; Salvatore Grisanti; Daniele Generali; Jose A Garcia-Saenz; Justin Stebbing; Carlos Caldas; Paola Gazzaniga; Luis Manso; Rita Zamarchi; Angela Fernandez de Lascoiti; Leticia De Mattos-Arruda; Michail Ignatiadis; Ronald Lebofsky; Steven J van Laere; Franziska Meier-Stiegen; Maria-Teresa Sandri; Jose Vidal-Martinez; Eleni Politaki; Francesca Consoli; Alberto Bottini; Eduardo Diaz-Rubio; Jonathan Krell; Sarah-Jane Dawson; Cristina Raimondi; Annemie Rutten; Wolfgang Janni; Elisabetta Munzone; Vicente Carañana; Sofia Agelaki; Camillo Almici; Luc Dirix; Erich-Franz Solomayer; Laura Zorzino; Helene Johannes; Jorge S Reis-Filho; Klaus Pantel; Jean-Yves Pierga; Stefan Michiels
Journal:  Lancet Oncol       Date:  2014-03-11       Impact factor: 41.316

Review 9.  Molecular biology of breast cancer metastasis. Clinical implications of experimental studies on metastatic inefficiency.

Authors:  A F Chambers; G N Naumov; S A Vantyghem; A B Tuck
Journal:  Breast Cancer Res       Date:  2000-07-21       Impact factor: 6.466

10.  Circulating tumor cells predict survival in early average-to-high risk breast cancer patients.

Authors:  Brigitte Rack; Christian Schindlbeck; Julia Jückstock; Ulrich Andergassen; Philip Hepp; Thomas Zwingers; Thomas W P Friedl; Ralf Lorenz; Hans Tesch; Peter A Fasching; Tanja Fehm; Andreas Schneeweiss; Werner Lichtenegger; Matthias W Beckmann; Klaus Friese; Klaus Pantel; Wolfgang Janni
Journal:  J Natl Cancer Inst       Date:  2014-05-15       Impact factor: 13.506

View more
  2 in total

1.  Isolation of Breast cancer CTCs with multitargeted buoyant immunomicrobubbles.

Authors:  Guankui Wang; Halli Benasutti; Jessica F Jones; Guixin Shi; Michael Benchimol; Sandeep Pingle; Santosh Kesari; Yasan Yeh; Li-En Hsieh; Yu-Tsueng Liu; Anthony Elias; Dmitri Simberg
Journal:  Colloids Surf B Biointerfaces       Date:  2017-10-23       Impact factor: 5.268

2.  Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases.

Authors:  Melissa García-Caballero; Jenny Paupert; Silvia Blacher; Maureen Van de Velde; Ana Rodríguez Quesada; Miguel Angel Medina; Agnès Noël
Journal:  J Hematol Oncol       Date:  2017-06-19       Impact factor: 17.388

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.